康恩貝 (600572.SS)

4.5100 +0.0400 (+0.89%) 市場開市。 截至 11:30AM CST。

康恩貝

Binjiang Science and Technology Economic Park
No. 568, Bingkang Road Hangzhou High-tech Development Zone
Hangzhou 310052
China
86 571 8777 4710
https://www.conbagroup.com

版塊: Healthcare
行業: Drug Manufacturers - Specialty & Generic
全職員工: 8,411

高階主管

名稱	頭銜	支付	行使價	出生年份
Mr. Guoliang Luo	President & Director	無	無	1963
Mr. Ming Chen	VP, CFO & Director	無	無	1977
Mr. Zucheng Jin	VP & Board Secretary	無	無	1976
Ms. Chunling Xu	Vice President	無	無	1969
Mr. Jianfeng Ye	VP & Director	無	無	1974

截止 為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 CNY。

描述

Zhejiang CONBA Pharmaceutical Co.,Ltd. engages in the research and development, manufacturing, and sales of medicines and general health products in China. It offers Chinese herbal decoction pieces, Chinese patent medicines, chemical pharmaceutical products, chemical raw materials, medical devices, and biological products. The company also provides pharmaceutical dosage forms, including tablets, capsules, pills, dripping pills, granules, powders, injections, freeze-dried powder injections, oral liquids, syrups, nasal drops, ointments, etc. The company was formerly known as Lanxi Yunshan Pharmaceutical Factory and changed its name to Zhejiang CONBA Pharmaceutical Co.,Ltd. in October 1999. Zhejiang CONBA Pharmaceutical Co.,Ltd. was founded in 1993 and is headquartered in Hangzhou, China. Zhejiang CONBA Pharmaceutical Co.,Ltd. is a subsidiary of Zhejiang Traditional Chinese Medicine Health Industry Group Co., Ltd.

公司管治

截至 無 止，康恩貝 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中：無；董事會：無；股東權利：無；現金賠償：無。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。